AFT to announce half year results on Nov 21 ’19

Market and Media release 11 October 2019


AFT Pharmaceuticals to announce half year results on Thursday November 21
2019


AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to
release on Thursday November 21 2019 its half year results for the period ended
September 30 2019. The release will be issued at around 09:00.

This will be followed by a presentation by management at 10:00 by
teleconference. The presentation material which will be referred to by
management will be issued at around 09:00 and will also be available on the
company’s website aftpharm.com.

To attend the conference call please dial in on one of the numbers below at
least five minutes before the scheduled call time, identify yourself to the
operator and provide the following confirmation code: 8476857

Confirmation code: 8476857

Phone numbers:

Australia +61 2 8038 5221 New Zealand +64 9 8876 907
1800 123 296 0800 452 782

For more information:


Investors Media
Malcolm Tubby Richard Inder
CFO, AFT Pharmaceuticals Ltd The Project
Phone: +64 9 488 0232 Phone: 021 645 643
Email: malcolm@aftpharm.com Email: richard@theproject.co.nz

About AFT Pharmaceuticals
AFT is a growing multinational pharmaceutical company that develops,
markets and distributes a broad portfolio of pharmaceutical products across a
wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over-the-counter (OTC), prescription
and hospital. Our product portfolio comprises both proprietary and in-licensed
products, and includes patented, branded and generic drugs. Our business
model is to develop and in-license products for sale by our own dedicated
sales teams in our home markets of Australia and New Zealand and in certain
Southeast Asian markets, and to out-license our products to local licensees
and distributors to the rest of the world. For more information:
https://www.aftpharm.com/